期刊文献+

幽门螺杆菌的耐药和治疗策略进展 被引量:5

原文传递
导出
摘要 幽门螺杆菌(Helicobacterpylori,Hp)感染的根除适应证在增加,但根除率却在下降。Hp根除率下降的原因虽有多种,但Hp耐药则是其最主要原因。目前临床上用于根除Hp的药物包括硝基咪唑类、大环内酯类、β-内酰胺类、喹诺酮类、四环素和呋喃唑酮等。随着抗菌药物的广泛应用,Hp的耐药性问题日益突出。现就近年Hp耐药性现状、耐药后治疗策略新进展作一介绍。
出处 《中国医师进修杂志》 2014年第7期3-5,共3页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献1

二级参考文献20

  • 1Yoshitsugu Tajima,Tamotsu Kuroki,Ryuji Tsutsumi,Ichiro Sakamoto,Masataka Uetani,Takashi Kanematsu.Extrahepatic collaterals and liver damage in embolotherapy for ruptured hepatic artery pseudoaneurysm following hepatobiliary pancreatic surgery[J].World Journal of Gastroenterology,2007,13(3):408-413. 被引量:8
  • 2NorazahAhmad,Wan RasinahZakaria,RamelahMohamed.Analysis of antibiotic susceptibility patterns of Helicobacter pylori isolates from Malaysia[J].Helicobacter.2011(1)
  • 3Alexander C.Ford,Anthony T. R.Axon.Epidemiology of Helicobacter pylori infection and Public Health Implications[J].Helicobacter.2010
  • 4JacquesFerlay,Hai‐RimShin,FreddieBray,DavidForman,ColinMathers,Donald MaxwellParkin.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J].Int J Cancer.2010(12)
  • 5Lucy Vannella,Edith Lahner,Cesare Bordi,Emanuela Pilozzi,Emilio Di Giulio,Vito D. Corleto,John Osborn,Gianfranco Delle Fave,Bruno Annibale.Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up[J].Digestive and Liver Disease.2010(4)
  • 6SeiichiKato,ShigeruFujimura.Primary antimicrobial resistance of Helicobacter pylori in children during the past 9 years[J].Pediatrics International.2010(2)
  • 7JosetteRaymond,DominiqueLamarque,NicolasKalach,StanislasChaussade,ChristopheBurucoa.High Level of Antimicrobial Resistance in French Helicobacter pylori Isolates[J].Helicobacter.2010(1)
  • 8F. Perna,A. Zullo,C. Ricci,C. Hassan,S. Morini,D. Vaira.Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: Role of bacterial resistance[J].Digestive and Liver Disease.2007(11)
  • 9L.FISCHBACH,E. L.EVANS.Meta‐analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first‐line therapies for Helicobacter pylori[J].Alimentary Pharmacology & Therapeutics.2007(3)
  • 10R.TAKENAKA,H.OKADA,J.KATO,C.MAKIDONO,S.HORI,Y.KAWAHARA,M.MIYOSHI,E.YUMOTO,A.IMAGAWA,T.TOYOKAWA,K.SAKAGUCHI,Y.SHIRATORI.Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type[J].Alimentary Pharmacology & Therapeutics.2007(7)

共引文献6

同被引文献56

引证文献5

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部